The science behind every personal plan.
Four technologies work together: neoantigen vaccine design, NK cell engineering, patient-derived organoids and AI analysis.
From a single sample to a personal solution.
Data moves forward from sample to solution. With consent, de-identified results feed back to improve the models.
- 01
Sequence
Tumor and blood DNA and RNA are sequenced to map the cancer’s mutations.
- 02
Predict
AI models predict which neoantigens the immune system is most likely to see.
- 03
Validate
Candidates and NK cells are tested against the patient’s own organoids.
- 04
Learn
With consent, de-identified results help improve the models over time.
Patient-derived organoids.
Organoids are three-dimensional mini-tumors that can keep many features of the patient’s cancer, including its mutations and structure.
Our scientific team’s background includes liver and biliary organoid research, and we are applying the same methods to other solid tumors. Each organoid line is documented, from sample source to the results it produced.
AI that learns from every patient.
From thousands of mutations in a tumor, AI helps identify the few most likely to be recognized by the immune system. Scientists review every result.
Neoantigen selection
Ranks thousands of candidate mutations to find the strongest vaccine targets.
Organoid imaging
Measures how organoids grow and respond, image by image.
NK cell profiling
Estimates NK cell activity against organoids in the laboratory.
Immune monitoring
Tracks the immune response over time and flags changes for the medical team.
Quality and safety at every step.
Traceability
Every sample and cell product carries a record from collection to delivery.
Release testing
Cell products must pass release testing in line with applicable Hong Kong requirements before use.
Medical oversight
Any treatment is prescribed and given only by registered doctors in licensed healthcare facilities.
Let’s talk about precision cell science.
Doctors can refer a patient, and hospitals, laboratories and investors can explore a partnership. Patients are welcome to contact us; any medical decision is made with your own doctor.